Inhibitor Therapeutics, Inc.

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Organon Will Market Lilly’s Emgality, R

Below is Scrip’s monthly roundup, including information from Strategic Transactions , of recent technology transfer agreements between companies and academic or other research institutions. Mustang

The progression of investigational products through a series of increasingly sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for commer

IN VITRO DIAGNOSTICS Mergers & Acquisitions Institut Merieux bioMerieux SA BioFire Diagnostics Inc. Leading diagnostics firm bioMerieux SA (a division of Institut Merieux ) has agreed to acquir